Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of MBX 2109 in Healthy Adult Subjects
Clinical trial NCT05158335 · COMPLETED
Trial details
- NCT number
- NCT05158335
- Sponsor
- MBX Biosciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-10
- Primary completion
- 2023-06-20
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.